期刊文献+

^(131)I-herceptin对乳腺癌细胞株的放射免疫治疗 被引量:9

Radioimmunotherapy of breast cancer cell lines with ^(131)I-herceptin
原文传递
导出
摘要 目的探索131I-herceptin对高表达Her-2基因的乳腺癌细胞株的生物学作用。方法 MTT比色法检测131I-herceptin对表达不同水平Her-2基因的三株乳腺癌细胞株SK-BR-3、MDA-MB-231、MCF-7的抑制作用,流式细胞术测量各干预组的DNA倍体和凋亡率。结果 131I-herceptin对SK-BR-3细胞的抑制作用明显强于对MDA-MB-231、MCF-7细胞的抑制作用(P<0.05、P<0.01),并且明显强于131I组、herceptin组以及131I+herceptin组(P<0.05);131I-herceptin组的凋亡率(37.71%)明显高于131I+herceptin组(14.61%)(P<0.05)、herceptin组(3.37%)和131I组(0.93%)(P<0.01)。各干预组都出现细胞周期的阻滞,131I-herceptin组最明显(73.19%)。结论 131I-herceptin对高表达Her-2基因的人乳腺癌细胞株SK-BR-3有明显的抑制和杀伤作用。 Objective To explore the biologic response of breast cancer cell lines highly expressing Her-2 gene to 131I-herceptin.Methods The inhibitory effect of 131I-herceptin on SK-BR-3,MDA-MB-231 and MCF-7 cell lines expressing different levels of Her-2 gene was evaluated with MTT assay.The DNA ploid and cell apoptosis rate of the intervention groups were evaluated by flow cytometery.Results The inhibitory effect of 131I-herceptin on SK-BR-3 cells was significantly higher than that on MDA-MB-231 orMCF-7 cells(P0.05),which was significantly higher than that of 131I group,herceptin group and 131I+herceptin group as well(P0.05).The apoptosis rate of 131I-herceptin group(37.71%) was significantly higher than that of 131I group(0.93%),herceptin group(3.37%) or 131I+herceptin group(14.61%)(P0.01).A significant cell cycle blockage was seen in all intervention groups,especially in 131I-herceptin group(73.19%).Conclusion 131I-herceptin has significant inhibiting and killing effect on human breast cancer cell line SK-BR-3 expressing high level of Her-2 gene.
出处 《江苏医药》 CAS CSCD 北大核心 2011年第11期1273-1275,F0003,共4页 Jiangsu Medical Journal
关键词 乳腺癌 131I-herceptin 放射免疫治疗 Breast cancer 131I-herceptin Radioimmunotherapy
  • 相关文献

参考文献5

  • 1Menard S, Tagliabue E, Campiglio M, et al. Role of Her-2 gene overexpression in breast carcinoma [J]. Cell Physiol, 2000,182(2) : 150-162. 被引量:1
  • 2Rae JM, Lippman ME. Evaluation of novel epidermal growth factor receptor tyrosine kinase inhibitor[J]. Breast Cancer Research and Treatment, 2004,83(2) : 99-107. 被引量:1
  • 3Grondahl-Hansen J, Peters HA, Van Putten WL, et al. Prognostic significance of the receptor for urokinase plasminogen activator in breast cancer[J]. Clin Cancer Res, 1995,1(10): 1079-1087. 被引量:1
  • 4Liang K, Lu Y, Jin WD, et al. Sensitization of breast cancer cells to radiation by trastuzumab[J]. Molecular Cancer Therapeutics,2003,2(11) : 1113-1120. 被引量:1
  • 5Pegram M, Hsu S, Lewis G, et al. Inhibitory effects of combin ations of Her-2/neu antibody and Chemotherape-utic agents used for treatment of human breast cancer[J]. Oncogene, 1999,18(13): 2241-2251. 被引量:1

同被引文献93

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部